Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT)

Molecular Psychiatry
T LenczA K Malhotra

Abstract

It has long been recognized that generalized deficits in cognitive ability represent a core component of schizophrenia (SCZ), evident before full illness onset and independent of medication. The possibility of genetic overlap between risk for SCZ and cognitive phenotypes has been suggested by the presence of cognitive deficits in first-degree relatives of patients with SCZ; however, until recently, molecular genetic approaches to test this overlap have been lacking. Within the last few years, large-scale genome-wide association studies (GWAS) of SCZ have demonstrated that a substantial proportion of the heritability of the disorder is explained by a polygenic component consisting of many common single-nucleotide polymorphisms (SNPs) of extremely small effect. Similar results have been reported in GWAS of general cognitive ability. The primary aim of the present study is to provide the first molecular genetic test of the classic endophenotype hypothesis, which states that alleles associated with reduced cognitive ability should also serve to increase risk for SCZ. We tested the endophenotype hypothesis by applying polygenic SNP scores derived from a large-scale cognitive GWAS meta-analysis (~5000 individuals from nine nonclinica...Continue Reading

References

Mar 17, 2001·Nature Reviews. Neuroscience·R Plomin
Apr 2, 2003·The American Journal of Psychiatry·Irving I Gottesman, Todd D Gould
Oct 13, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·David C GlahnMichael A Escamilla
May 13, 2008·Biological Psychiatry·Dwight DickinsonRuben C Gur
Mar 19, 2009·Human Genetics·Ian J DearyL M Houlihan
Jul 3, 2009·Nature·UNKNOWN International Schizophrenia ConsortiumPamela Sklar
Jul 17, 2009·Nature·Dominique J Charron
Feb 11, 2010·Nature Reviews. Neuroscience·Ian J DearyWendy Johnson
Jun 22, 2010·Nature Genetics·Jian YangPeter M Visscher
Sep 8, 2010·Archives of General Psychiatry·Timothea ToulopoulouRobin M Murray
Sep 14, 2010·Biological Psychiatry·Masashi IkedaNakao Iwata
Mar 17, 2011·European Journal of Human Genetics : EJHG·Jian YangUNKNOWN GIANT Consortium
May 12, 2011·Neuropharmacology·Francesco PapaleoDaniel R Weinberger
Jul 30, 2011·Schizophrenia Bulletin·Axel KrugTilo Kircher
Aug 4, 2011·PLoS Genetics·Stephen B MontgomeryEmmanouil T Dermitzakis
Aug 6, 2011·Trends in Cognitive Sciences·Robert M BilderD Stott Parker
Sep 6, 2011·Human Molecular Genetics·Jingyuan FuCisca Wijmenga
Sep 20, 2011·Nature Genetics·UNKNOWN Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium
Dec 6, 2011·Nature Methods·Olivier DelaneauJean-François Zagury
Mar 3, 2012·G3 : Genes - Genomes - Genetics·Bryan HowieMatthew Stephens
Mar 27, 2012·Molecular Psychiatry·A Androutsellis-TheotokisS R Bornstein
Aug 4, 2012·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Emma J RoseGary Donohoe
Oct 3, 2012·Handbook of Experimental Pharmacology·Richard S E Keefe, Philip D Harvey
Oct 9, 2012·Biological Psychiatry·Afke F Terwisscha van ScheltingaUNKNOWN Psychiatric Genome-wide Association Study Consortium
Dec 1, 2012·Psychological Medicine·G DonohoeK E Burdick
Jan 18, 2013·JAMA Psychiatry·Saurav GuhaUNKNOWN Wellcome Trust Case Control Consortium 2
Mar 19, 2013·Psychological Science·Robert PlominOliver S P Davis
Aug 21, 2013·American Journal of Human Genetics·Teresa R de CandiaMatthew C Keller
Aug 27, 2013·Nature Genetics·Stephan RipkePatrick F Sullivan

❮ Previous
Next ❯

Citations

Jul 23, 2014·Translational Psychiatry·J J McGrathL Petersen
Sep 14, 2014·Social Psychiatry and Psychiatric Epidemiology·Daniel W BelskySalomon Israel
Feb 14, 2016·Schizophrenia Bulletin·David T LiebersFernando S Goes
Sep 13, 2015·Current Opinion in Neurobiology·Winifred Mark, Timothea Toulopoulou
Feb 26, 2016·BMC Psychiatry·Anna MosiołekAgata Szulc
Jan 16, 2016·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·David C GlahnGodfrey D Pearlson
Dec 19, 2015·Schizophrenia Bulletin·Leon HubbardStanley Zammit
Jul 1, 2014·Genes, Brain, and Behavior·A ChristoforouS Le Hellard
Jul 22, 2014·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Eveline L de ZeeuwDorret I Boomsma
Oct 31, 2015·Brain and Behavior·Craig MyrumClive R Bramham
Sep 24, 2015·Molecular Psychiatry·D P HowriganM C Keller
May 13, 2015·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Alex HatzimanolisDimitrios Avramopoulos
May 9, 2015·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Joey W TrampushAnil K Malhotra
Mar 6, 2015·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Mei-Hua HallJordan W Smoller
Aug 12, 2014·European Journal of Pharmacology·Annetrude J G de Mooij-van MalsenMartien J Kas
May 12, 2015·Journal of Cognitive Neuroscience·Matthew A ScultAhmad R Hariri
Feb 11, 2014·Biological Psychiatry·Daniel Paul Eisenberg, Karen F Berman
Feb 6, 2015·Neuroscience Bulletin·Jingchun ChenXiangning Chen
Oct 25, 2014·Biodemography and Social Biology·Daniel W Belsky, Salomon Israel
Jul 26, 2016·Frontiers in Neuroscience·Bernard J Crespi
Aug 4, 2015·Schizophrenia Research·Crystal C Watkins, Sarah Ramsay Andrews
Oct 16, 2016·Behavior Genetics·Chelsie E BencaNaomi P Friedman
Nov 23, 2016·Schizophrenia Bulletin·David L Braff, Carol A Tamminga
Mar 1, 2017·Psychological Medicine·T E Van RheenenK E Burdick
Jul 25, 2017·Psychological Medicine·J Mollon, A Reichenberg
Oct 25, 2017·Brain Imaging and Behavior·Ashlee A MooreAnna R Docherty
Aug 30, 2017·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Siri RanlundElvira Bramon
Apr 7, 2017·Disease Models & Mechanisms·Amelie Baud, Jonathan Flint
Apr 28, 2018·Schizophrenia Bulletin·Jennie G Pouget
Mar 14, 2018·Schizophrenia Bulletin·Amanda B ZheutlinTyrone D Cannon
Sep 23, 2018·Acta Psychiatrica Scandinavica·Md A IslamUNKNOWN GROUP Investigators
Feb 28, 2018·Nature Communications·Cui-Ping YangXiong-Jian Luo

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCA

Software Mentioned

PLINK
IMPUTE2
SHAPEIT
SVS
COGENT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.